Raymond James & Associates BIODELIVERY SCIENCES INTL IN Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Shares

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 11, 2022	SELL	N/A	-94,147 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	N/A	13,088 Added 16.15%	94,147 $292,000
Q3 2021 Nov 02, 2021	SELL	N/A	-1,000 Reduced 1.22%	81,059 $293,000
Q2 2021 Aug 11, 2021	BUY	N/A	9,359 Added 12.87%	82,059 $294,000
Q1 2021 May 14, 2021	BUY	N/A	714 Added 0.99%	72,700 $284,000
Q4 2020 Feb 12, 2021	BUY	N/A	7,500 Added 11.63%	71,986 $302,000
Q3 2020 Nov 04, 2020	BUY	N/A	4,100 Added 6.79%	64,486 $241,000
Q2 2020 Jul 28, 2020	SELL	N/A	-10,300 Reduced 14.57%	60,386 $263,000
Q1 2020 Apr 21, 2020	BUY	N/A	4,919 Added 7.48%	70,686 $268,000
Q4 2019 Feb 12, 2020	BUY	N/A	18,056 Added 37.84%	65,767 $416,000
Q3 2019 Nov 07, 2019	BUY	N/A	1,500 Added 3.25%	47,711 $201,000
Q4 2018 Feb 11, 2019	BUY	N/A	6,000 Added 14.92%	46,211 $171,000
Q3 2018 Nov 14, 2018	BUY	N/A	40,211 New	40,211 $113,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.